The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3247980)

Published in J Biol Chem on October 13, 2011

Authors

J Enrique Salcedo-Sora1, Edwin Ochong, Susan Beveridge, David Johnson, Alexis Nzila, Giancarlo A Biagini, Paul A Stocks, Paul M O'Neill, Sanjeev Krishna, Patrick G Bray, Stephen A Ward

Author Affiliations

1: Molecular and Biochemical Parasitology Group, Liverpool School of Tropical Medicine, Liverpool L3 5QA, United Kingdom.

Articles cited by this

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res (1997) 175.36

Human malaria parasites in continuous culture. Science (1976) 59.70

GenBank. Nucleic Acids Res (2007) 16.92

The HMMTOP transmembrane topology prediction server. Bioinformatics (2001) 12.57

Major facilitator superfamily. Microbiol Mol Biol Rev (1998) 9.77

Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science (2003) 7.96

PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res (2003) 6.19

Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell (2006) 4.84

Suppression of malaria (P. berghei) by milk. Br Med J (1952) 4.55

Mechanisms of resistance of malaria parasites to antifolates. Pharmacol Rev (2005) 4.04

Evidence for the shikimate pathway in apicomplexan parasites. Nature (1998) 3.60

Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase. Nat Methods (2006) 3.32

Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol (2003) 3.20

The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17

Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol Biochem Parasitol (2004) 3.13

Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother (2007) 3.08

TEXshade: shading and labeling of multiple sequence alignments using LATEX2 epsilon. Bioinformatics (2000) 2.54

Maintenance of Xenopus laevis and oocyte injection. Methods Enzymol (1992) 2.53

In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob Agents Chemother (1985) 2.07

The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood (2007) 1.95

The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum. Genome Biol (2005) 1.91

A novel loss-of-function mutation in the proton-coupled folate transporter from a patient with hereditary folate malabsorption reveals that Arg 113 is crucial for function. Blood (2008) 1.55

New perspectives on folate catabolism. Annu Rev Nutr (2001) 1.54

Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem (1995) 1.42

Quantitation of in vivo human folate metabolism. Am J Clin Nutr (2004) 1.41

PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol Microbiol (2006) 1.33

Blood folate levels: the latest NHANES results. NCHS Data Brief (2008) 1.32

Higher plant plastids and cyanobacteria have folate carriers related to those of trypanosomatids. J Biol Chem (2005) 1.29

Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol (1985) 1.26

The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results. Am J Trop Med Hyg (1986) 1.25

Plant homologs of the Plasmodium falciparum chloroquine-resistance transporter, PfCRT, are required for glutathione homeostasis and stress responses. Proc Natl Acad Sci U S A (2010) 1.24

The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. J Protozool (1973) 1.22

De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol (1989) 1.22

T(E)Xtopo: shaded membrane protein topology plots in LAT(E)X2epsilon. Bioinformatics (2000) 1.21

Exploring the folate pathway in Plasmodium falciparum. Acta Trop (2005) 1.20

Plasmodium falciparum in continuous culture: a new medium for the in vitro test for sulfadoxine sensitivity. Bull World Health Organ (1982) 1.20

Use of the tac promoter and lacIq for the controlled expression of Zymomonas mobilis fermentative genes in Escherichia coli and Zymomonas mobilis. J Bacteriol (1992) 1.14

Characterization of mutations that allow p-aminobenzoyl-glutamate utilization by Escherichia coli. J Bacteriol (1998) 1.12

Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol Microbiol (1999) 1.11

A modified in vitro sulfadoxine susceptibility assay for Plasmodium falciparum suitable for investigating Fansidar resistance. Parasitology (1997) 1.09

Cloning and functional expression of an MIP (AQP0) homolog from killifish (Fundulus heteroclitus) lens. Am J Physiol Regul Integr Comp Physiol (2001) 1.06

Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol (2008) 1.03

Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitol Res (2008) 1.00

Intracellular trafficking/membrane targeting of human reduced folate carrier expressed in Xenopus oocytes. Am J Physiol Gastrointest Liver Physiol (2001) 0.99

Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (2004) 0.98

Effect of milk diet on P. cynomolgi infections in monkeys. Br Med J (1953) 0.97

Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum. Clin Chem (2009) 0.97

Chemosensitization of Plasmodium falciparum by probenecid in vitro. Antimicrob Agents Chemother (2003) 0.94

Escherichia coli abg genes enable uptake and cleavage of the folate catabolite p-aminobenzoyl-glutamate. J Bacteriol (2007) 0.93

Transfection of the human malaria parasite Plasmodium falciparum. Int J Parasitol (1999) 0.93

Growth phase regulation of the main folate transporter of Leishmania infantum and its role in methotrexate resistance. J Biol Chem (2004) 0.92

Milk, p-aminobenzoate, and malaria of rats and monkeys. Br Med J (1954) 0.92

Oxidation of cysteine 645 of cobalamin-independent methionine synthase causes a methionine limitation in Escherichia coli. J Bacteriol (2009) 0.91

Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Trop Med Int Health (2004) 0.91

Auxotrophs of Plasmodium falciparum dependent on p-aminobenzoic acid for growth. Proc Natl Acad Sci U S A (1994) 0.91

Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection. J Infect Dis (2003) 0.90

Optimal concentration of p-aminobenzoic acid and folic acid in the in vitro assay of antifolates against Plasmodium falciparum. Am J Trop Med Hyg (1987) 0.89

[The importance of p-aminobenzoic acid to the course and immunity of malaria in animals (Plasmodium berghei) and in man (Pl. falciparum). 3. Studies on children experimentally fed on milk]. Z Tropenmed Parasitol (1966) 0.86

[The importance of p-aminobenzoic acid to the course and immunity of malaria in animals (Plasmodium berghei) and in man (Pl. falciparum). I. Studies on NMRI mice]. Z Tropenmed Parasitol (1966) 0.86

Structure-function analysis of the highly conserved charged residues of the membrane protein FT1, the main folic acid transporter of the protozoan parasite Leishmania. Biochem Pharmacol (2009) 0.85

Plasmodium falciparum: variations in p-aminobenzoic acid requirements as related to sulfadoxine sensitivity. Exp Parasitol (1983) 0.85

Continuous cultivation and improved drug responsiveness of Plasmodium falciparum in p-aminobenzoic acid-deficient medium. J Parasitol (1983) 0.85

Identification of transport-critical residues in a folate transporter from the folate-biopterin transporter (FBT) family. J Biol Chem (2009) 0.83

Characterisation of exogenous folate transport in Plasmodium falciparum. Mol Biochem Parasitol (2007) 0.83

The methionine synthesis cycle and salvage of methyltetrahydrofolate from host red cells in the malaria parasite (Plasmodium falciparum). Parasitology (1993) 0.83

[The importance of p-aminobenzoic acid to the course and immunity of malaria in animals (Plasmodium berghei) and in man (Pl. falciparum). II. Studies on naturally fed small children]. Z Tropenmed Parasitol (1966) 0.82

An endogenous carrier-mediated uptake system for folate in oocytes of Xenopus laevis. Proc Biol Sci (1991) 0.80

Articles by these authors

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67

The genome of the African trypanosome Trypanosoma brucei. Science (2005) 11.48

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med (2005) 10.58

The American Board of Internal Medicine: evolving professional self-regulation. Ann Intern Med (2014) 7.65

The DNA sequence of the human X chromosome. Nature (2005) 6.97

The trypanosomiases. Lancet (2003) 5.96

Literature Review of Florida Red Tide: Implications for Human Health Effects. Harmful Algae (2004) 5.00

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med (2002) 4.89

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57

Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature (2012) 4.37

Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis (2006) 4.21

Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin Infect Dis (2006) 4.14

Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis (2008) 4.07

Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J (2004) 3.80

Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat Genet (2006) 3.68

Antimalarial combinations. Lancet (2004) 3.54

Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma. Environ Health Perspect (2005) 3.38

The preoperative incidence of raised intracranial pressure in nonsyndromic sagittal craniosynostosis is underestimated in the literature. J Neurosurg Pediatr (2014) 3.30

Occupational exposure to aerosolized brevetoxins during Florida red tide events: effects on a healthy worker population. Environ Health Perspect (2005) 3.27

Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21

A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol (2005) 3.18

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol (2005) 3.09

Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06

Crystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domain. J Biol Chem (2002) 3.01

Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol Biol Evol (2006) 3.01

Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis. BMJ (2011) 3.00

Plasmodium falciparum: sacrificing membrane to grow crystals? Trends Parasitol (2003) 2.96

Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet (2006) 2.96

Ultralow thermal conductivity in disordered, layered WSe2 crystals. Science (2006) 2.79

An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med (2002) 2.69

Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis (2005) 2.58

The molecular mechanism of action of artemisinin--the debate continues. Molecules (2010) 2.57

The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle. Trends Parasitol (2007) 2.54

Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. Trans R Soc Trop Med Hyg (2006) 2.52

In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother (2009) 2.36

Severe falciparum malaria in Gabonese children: clinical and laboratory features. Malar J (2005) 2.35

Does telephone triage delay significant medical treatment?: Advice nurse service vs on-call pediatricians. Arch Pediatr Adolesc Med (2003) 2.25

Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24

Caller satisfaction with after-hours telephone advice: nurse advice service versus on-call pediatricians. Pediatrics (2002) 2.24

A novel and accurate diagnostic test for human African trypanosomiasis. Lancet (2004) 2.22

The incidence of raised intracranial pressure in nonsyndromic sagittal craniosynostosis following primary surgery. J Neurosurg Pediatr (2015) 2.20

The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop Med Int Health (2007) 2.17

Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med (2003) 2.13

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11

Core competencies in the science and practice of knowledge translation: description of a Canadian strategic training initiative. Implement Sci (2011) 2.09

A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J (2005) 2.09

Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. Crit Care Med (2007) 2.04

Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science (2005) 2.03

Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol Cell (2004) 2.02

Low salivary cortisol levels and externalizing behavior problems in youth. Dev Psychopathol (2005) 2.01

Coartem (artemether-lumefantrine) in Africa: the beginning of the end? J Infect Dis (2005) 2.00

Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS One (2011) 2.00

Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol (2006) 1.99

Global perspectives for prevention of infectious diseases associated with mass gatherings. Lancet Infect Dis (2012) 1.99

Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test. Lancet (2005) 1.94

A prospective comparison of malaria with other severe diseases in African children: prognosis and optimization of management. Clin Infect Dis (2003) 1.93

Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89

Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet (2002) 1.88

Chloroquine resistance before and after its withdrawal in Kenya. Malar J (2009) 1.88

Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat Genet (2013) 1.87

Glycan receptor binding of the influenza A virus H7N9 hemagglutinin. Cell (2013) 1.84

Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82

Root traits predict decomposition across a landscape-scale grazing experiment. New Phytol (2014) 1.80

Human African trypanosomiasis. BMJ (2002) 1.79

Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum (2002) 1.76

Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther (2004) 1.76

Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol (2003) 1.74

Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics (2010) 1.73

Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am J Trop Med Hyg (2003) 1.72

Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar J (2010) 1.72

Reoperation for intracranial hypertension in TWIST1-confirmed Saethre-Chotzen syndrome: a 15-year review. Plast Reconstr Surg (2009) 1.68

Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis (2003) 1.67

Benefits of off-pump bypass on neurologic and clinical morbidity: a prospective randomized trial. Ann Thorac Surg (2003) 1.67

Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer (2005) 1.65

Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert Opin Pharmacother (2007) 1.64

Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol (2005) 1.64

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res (2009) 1.64

International multicenter investigation of LB20304, a new fluoronaphthyridone. Clin Microbiol Infect (1998) 1.60

Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea. Clin Infect Dis (2006) 1.59

Cytochrome P450 6M2 from the malaria vector Anopheles gambiae metabolizes pyrethroids: Sequential metabolism of deltamethrin revealed. Insect Biochem Mol Biol (2011) 1.59

Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria. Antimicrob Agents Chemother (2002) 1.59

Late neurologic and cognitive sequelae of inflicted traumatic brain injury in infancy. Pediatrics (2005) 1.59

Frontorhiny, a distinctive presentation of frontonasal dysplasia caused by recessive mutations in the ALX3 homeobox gene. Am J Hum Genet (2009) 1.57

Sexual dysfunction in women with ESRD requiring hemodialysis. Clin J Am Soc Nephrol (2012) 1.56

Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS One (2012) 1.55

Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis (2016) 1.53

History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. Wien Klin Wochenschr (2007) 1.52

Health service costs for patients on the waiting list. Can J Surg (2002) 1.52

Recent highlights in antimalarial drug resistance and chemotherapy research. Trends Parasitol (2008) 1.52

Assessment of volume depletion in children with malaria. PLoS Med (2004) 1.51

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg (2014) 1.51

Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. J Infect Dis (2006) 1.49

Massive levothyroxine ingestion in a pediatric patient: case report and discussion. CJEM (2011) 1.48